Viewing nowCombinationVartanex Tablet 10/160 mg
Amlodipine Besylate 13.87mg · Valsartan 160mg
Tablet · Prescription medication · Combination
Donggwang Pharmaceutical Co., Ltd.

MFDS item code 201308572 · Approved 2013.07.31 · Insurance code 645905480
Treatment of essential hypertension not adequately controlled with monotherapy
This medication helps lower blood pressure effectively and prevents cardiovascular complications in patients with essential hypertension who do not have sufficient blood pressure control with amlodipine or valsartan as monotherapy. This treatment is used to help achieve proper management for those experiencing difficulties in blood pressure control and improve vascular health.
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that the tablet be taken at the same time each day (e.g., in the morning). It is recommended that the doses of the individual components (amlodipine or valsartan) be adjusted before this medicine is administered. However, if blood pressure is not controlled with monotherapy with the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 mg or valsartan 80 mg. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 mg or valsartan 160 mg. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 10 mg or valsartan 160 mg, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater). This medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.
This medication can cause serious harm to the fetus and newborn if taken during the second or third trimester of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients who are allergic to any components of this medication or similar class drugs, pregnant or breastfeeding women, and patients with severe kidney or liver dysfunction should not take this medication. Patients with low body sodium or fluid levels may experience low blood pressure upon initial dosing, so their condition should be carefully assessed before taking this medication, and blood pressure should be closely monitored during treatment. Patients with high potassium levels should be cautious when taking this drug along with medications that can increase potassium, and frequent monitoring of serum potassium levels is recommended. Patients with renal artery stenosis or those who have recently undergone kidney transplants should use this medication cautiously as it may affect kidney function. If angioedema (such as airway obstruction or swelling of the face, lips, or tongue) occurs, discontinue the medication immediately and do not re-administer. Patients with heart failure or those recovering from a myocardial infarction should carefully monitor changes in kidney function and blood pressure when taking this medication, as some patients may experience increased pulmonary edema. This medication is used for the treatment of hypertension and is effective in lowering blood pressure; however, overdose may lead to severe hypotension, dizziness, and cardiac arrhythmias, so caution is required. Dizziness or fatigue may occur while driving or operating machinery, so caution is advised, especially upon initial dosing or when adjusting the dose. Interactions may occur when taken with other medications; therefore, if you are currently taking other medications, discuss it with your doctor or pharmacist. It is recommended that women who are pregnant or planning to become pregnant, as well as breastfeeding women, do not use this medication, as it may pose risks to the fetus during pregnancy. This medication is not recommended for children under 18 years of age as safety and efficacy have not been established for this age group. Elderly patients may take doses similar to those for adults but may require caution based on their physical condition. Adverse reactions may include headache, dizziness, edema, hypotension, skin rash, etc., and if symptoms are severe or persistent, immediate consultation with healthcare professionals is necessary.
nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, orthostatic dizziness, sensory disturbances, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, oropharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, thirst, rash, erythema, hyperhidrosis, pruritus, joint swelling, low back pain, arthritis, muscle spasm, lethargy, polyuria, nocturia, erectile dysfunction, edema, peripheral edema, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, diplopia, thrombocytopenic purpura, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremor, sensory loss, taste disturbance, peripheral neuropathy, excessive muscle hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, dysuria, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux, neck pain, hypercholesterolemia, hypoglycemia, neuroexcitability, Stevens-Johnson syndrome, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is advisable to maintain storage temperatures between 1 degree and 30 degrees Celsius in room temperature.
Bright yellow oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 13.87mg · Valsartan 160mg
Tablet · Prescription medication · Combination
Donggwang Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.